Report Detail

Other Global Personalized Medicines In Oncology Market Size, Status and Forecast 2021-2027

  • RnM4281741
  • |
  • 28 January, 2021
  • |
  • Global
  • |
  • 96 Pages
  • |
  • QYResearch
  • |
  • Other

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Personalized Medicines In Oncology Market Size Growth Rate by Service: 2016 VS 2021 VS 2027
    • 1.2.2 Molecular Oncopathology
    • 1.2.3 Genome Diagnostics
    • 1.2.4 Radiation Therapy
    • 1.2.5 Oncology Testing
    • 1.2.6 Chemotherapy
    • 1.2.7 Others
  • 1.3 Market by Application
    • 1.3.1 Global Personalized Medicines In Oncology Market Share by End Users: 2016 VS 2021 VS 2027
    • 1.3.2 Research Centers
    • 1.3.3 Governmental Institutions
    • 1.3.4 Hospitals
    • 1.3.5 Clinical Centers
    • 1.3.6 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Personalized Medicines In Oncology Market Perspective (2016-2027)
  • 2.2 Personalized Medicines In Oncology Growth Trends by Regions
    • 2.2.1 Personalized Medicines In Oncology Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Personalized Medicines In Oncology Historic Market Share by Regions (2016-2021)
    • 2.2.3 Personalized Medicines In Oncology Forecasted Market Size by Regions (2022-2027)
  • 2.3 Personalized Medicines In Oncology Industry Dynamic
    • 2.3.1 Personalized Medicines In Oncology Market Trends
    • 2.3.2 Personalized Medicines In Oncology Market Drivers
    • 2.3.3 Personalized Medicines In Oncology Market Challenges
    • 2.3.4 Personalized Medicines In Oncology Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Personalized Medicines In Oncology Players by Revenue
    • 3.1.1 Global Top Personalized Medicines In Oncology Players by Revenue (2016-2021)
    • 3.1.2 Global Personalized Medicines In Oncology Revenue Market Share by Players (2016-2021)
  • 3.2 Global Personalized Medicines In Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Personalized Medicines In Oncology Revenue
  • 3.4 Global Personalized Medicines In Oncology Market Concentration Ratio
    • 3.4.1 Global Personalized Medicines In Oncology Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Personalized Medicines In Oncology Revenue in 2020
  • 3.5 Personalized Medicines In Oncology Key Players Head office and Area Served
  • 3.6 Key Players Personalized Medicines In Oncology Product Solution and Service
  • 3.7 Date of Enter into Personalized Medicines In Oncology Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Personalized Medicines In Oncology Breakdown Data by Service

  • 4.1 Global Personalized Medicines In Oncology Historic Market Size by Service (2016-2021)
  • 4.2 Global Personalized Medicines In Oncology Forecasted Market Size by Service (2022-2027)

5 Personalized Medicines In Oncology Breakdown Data by End Users

  • 5.1 Global Personalized Medicines In Oncology Historic Market Size by End Users (2016-2021)
  • 5.2 Global Personalized Medicines In Oncology Forecasted Market Size by End Users (2022-2027)

6 North America

  • 6.1 North America Personalized Medicines In Oncology Market Size (2016-2027)
  • 6.2 North America Personalized Medicines In Oncology Market Size by Service
    • 6.2.1 North America Personalized Medicines In Oncology Market Size by Service (2016-2021)
    • 6.2.2 North America Personalized Medicines In Oncology Market Size by Service (2022-2027)
    • 6.2.3 North America Personalized Medicines In Oncology Market Size by Service (2016-2027)
  • 6.3 North America Personalized Medicines In Oncology Market Size by End Users
    • 6.3.1 North America Personalized Medicines In Oncology Market Size by End Users (2016-2021)
    • 6.3.2 North America Personalized Medicines In Oncology Market Size by End Users (2022-2027)
    • 6.3.3 North America Personalized Medicines In Oncology Market Size by End Users (2016-2027)
  • 6.4 North America Personalized Medicines In Oncology Market Size by Country
    • 6.4.1 North America Personalized Medicines In Oncology Market Size by Country (2016-2021)
    • 6.4.2 North America Personalized Medicines In Oncology Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.3 Canada

7 Europe

  • 7.1 Europe Personalized Medicines In Oncology Market Size (2016-2027)
  • 7.2 Europe Personalized Medicines In Oncology Market Size by Service
    • 7.2.1 Europe Personalized Medicines In Oncology Market Size by Service (2016-2021)
    • 7.2.2 Europe Personalized Medicines In Oncology Market Size by Service (2022-2027)
    • 7.2.3 Europe Personalized Medicines In Oncology Market Size by Service (2016-2027)
  • 7.3 Europe Personalized Medicines In Oncology Market Size by End Users
    • 7.3.1 Europe Personalized Medicines In Oncology Market Size by End Users (2016-2021)
    • 7.3.2 Europe Personalized Medicines In Oncology Market Size by End Users (2022-2027)
    • 7.3.3 Europe Personalized Medicines In Oncology Market Size by End Users (2016-2027)
  • 7.4 Europe Personalized Medicines In Oncology Market Size by Country
    • 7.4.1 Europe Personalized Medicines In Oncology Market Size by Country (2016-2021)
    • 7.4.2 Europe Personalized Medicines In Oncology Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Personalized Medicines In Oncology Market Size (2016-2027)
  • 8.2 Asia-Pacific Personalized Medicines In Oncology Market Size by Service
    • 8.2.1 Asia-Pacific Personalized Medicines In Oncology Market Size by Service (2016-2021)
    • 8.2.2 Asia-Pacific Personalized Medicines In Oncology Market Size by Service (2022-2027)
    • 8.2.3 Asia-Pacific Personalized Medicines In Oncology Market Size by Service (2016-2027)
  • 8.3 Asia-Pacific Personalized Medicines In Oncology Market Size by End Users
    • 8.3.1 Asia-Pacific Personalized Medicines In Oncology Market Size by End Users (2016-2021)
    • 8.3.2 Asia-Pacific Personalized Medicines In Oncology Market Size by End Users (2022-2027)
    • 8.3.3 Asia-Pacific Personalized Medicines In Oncology Market Size by End Users (2016-2027)
  • 8.4 Asia-Pacific Personalized Medicines In Oncology Market Size by Region
    • 8.4.1 Asia-Pacific Personalized Medicines In Oncology Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Personalized Medicines In Oncology Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Personalized Medicines In Oncology Market Size (2016-2027)
  • 9.2 Latin America Personalized Medicines In Oncology Market Size by Service
    • 9.2.1 Latin America Personalized Medicines In Oncology Market Size by Service (2016-2021)
    • 9.2.2 Latin America Personalized Medicines In Oncology Market Size by Service (2022-2027)
    • 9.2.3 Latin America Personalized Medicines In Oncology Market Size by Service (2016-2027)
  • 9.3 Latin America Personalized Medicines In Oncology Market Size by End Users
    • 9.3.1 Latin America Personalized Medicines In Oncology Market Size by End Users (2016-2021)
    • 9.3.2 Latin America Personalized Medicines In Oncology Market Size by End Users (2022-2027)
    • 9.3.3 Latin America Personalized Medicines In Oncology Market Size by End Users (2016-2027)
  • 9.4 Latin America Personalized Medicines In Oncology Market Size by Country
    • 9.4.1 Latin America Personalized Medicines In Oncology Market Size by Country (2016-2021)
    • 9.4.2 Latin America Personalized Medicines In Oncology Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Personalized Medicines In Oncology Market Size (2016-2027)
  • 10.2 Middle East & Africa Personalized Medicines In Oncology Market Size by Service
    • 10.2.1 Middle East & Africa Personalized Medicines In Oncology Market Size by Service (2016-2021)
    • 10.2.2 Middle East & Africa Personalized Medicines In Oncology Market Size by Service (2022-2027)
    • 10.2.3 Middle East & Africa Personalized Medicines In Oncology Market Size by Service (2016-2027)
  • 10.3 Middle East & Africa Personalized Medicines In Oncology Market Size by End Users
    • 10.3.1 Middle East & Africa Personalized Medicines In Oncology Market Size by End Users (2016-2021)
    • 10.3.2 Middle East & Africa Personalized Medicines In Oncology Market Size by End Users (2022-2027)
    • 10.3.3 Middle East & Africa Personalized Medicines In Oncology Market Size by End Users (2016-2027)
  • 10.4 Middle East & Africa Personalized Medicines In Oncology Market Size by Country
    • 10.4.1 Middle East & Africa Personalized Medicines In Oncology Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Personalized Medicines In Oncology Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Biotheranostics
    • 11.1.1 Biotheranostics Company Details
    • 11.1.2 Biotheranostics Business Overview
    • 11.1.3 Biotheranostics Personalized Medicines In Oncology Introduction
    • 11.1.4 Biotheranostics Revenue in Personalized Medicines In Oncology Business (2016-2021)
    • 11.1.5 Biotheranostics Recent Development
  • 11.2 Illumina
    • 11.2.1 Illumina Company Details
    • 11.2.2 Illumina Business Overview
    • 11.2.3 Illumina Personalized Medicines In Oncology Introduction
    • 11.2.4 Illumina Revenue in Personalized Medicines In Oncology Business (2016-2021)
    • 11.2.5 Illumina Recent Development
  • 11.3 DNA Link
    • 11.3.1 DNA Link Company Details
    • 11.3.2 DNA Link Business Overview
    • 11.3.3 DNA Link Personalized Medicines In Oncology Introduction
    • 11.3.4 DNA Link Revenue in Personalized Medicines In Oncology Business (2016-2021)
    • 11.3.5 DNA Link Recent Development
  • 11.4 Genomic Health, Inc.(Exact Sciences)
    • 11.4.1 Genomic Health, Inc.(Exact Sciences) Company Details
    • 11.4.2 Genomic Health, Inc.(Exact Sciences) Business Overview
    • 11.4.3 Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Introduction
    • 11.4.4 Genomic Health, Inc.(Exact Sciences) Revenue in Personalized Medicines In Oncology Business (2016-2021)
    • 11.4.5 Genomic Health, Inc.(Exact Sciences) Recent Development
  • 11.5 Cypher Genomics(Human Longevity, Inc.)
    • 11.5.1 Cypher Genomics(Human Longevity, Inc.) Company Details
    • 11.5.2 Cypher Genomics(Human Longevity, Inc.) Business Overview
    • 11.5.3 Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Introduction
    • 11.5.4 Cypher Genomics(Human Longevity, Inc.) Revenue in Personalized Medicines In Oncology Business (2016-2021)
    • 11.5.5 Cypher Genomics(Human Longevity, Inc.) Recent Development
  • 11.6 Life Technologies Corporation(Thermo Fisher Scientific)
    • 11.6.1 Life Technologies Corporation(Thermo Fisher Scientific) Company Details
    • 11.6.2 Life Technologies Corporation(Thermo Fisher Scientific) Business Overview
    • 11.6.3 Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Introduction
    • 11.6.4 Life Technologies Corporation(Thermo Fisher Scientific) Revenue in Personalized Medicines In Oncology Business (2016-2021)
    • 11.6.5 Life Technologies Corporation(Thermo Fisher Scientific) Recent Development
  • 11.7 Fulgent Genetics
    • 11.7.1 Fulgent Genetics Company Details
    • 11.7.2 Fulgent Genetics Business Overview
    • 11.7.3 Fulgent Genetics Personalized Medicines In Oncology Introduction
    • 11.7.4 Fulgent Genetics Revenue in Personalized Medicines In Oncology Business (2016-2021)
    • 11.7.5 Fulgent Genetics Recent Development
  • 11.8 Caris Life Sciences
    • 11.8.1 Caris Life Sciences Company Details
    • 11.8.2 Caris Life Sciences Business Overview
    • 11.8.3 Caris Life Sciences Personalized Medicines In Oncology Introduction
    • 11.8.4 Caris Life Sciences Revenue in Personalized Medicines In Oncology Business (2016-2021)
    • 11.8.5 Caris Life Sciences Recent Development
  • 11.9 Ariana Pharma
    • 11.9.1 Ariana Pharma Company Details
    • 11.9.2 Ariana Pharma Business Overview
    • 11.9.3 Ariana Pharma Personalized Medicines In Oncology Introduction
    • 11.9.4 Ariana Pharma Revenue in Personalized Medicines In Oncology Business (2016-2021)
    • 11.9.5 Ariana Pharma Recent Development
  • 11.10 Abbott Laboratories
    • 11.10.1 Abbott Laboratories Company Details
    • 11.10.2 Abbott Laboratories Business Overview
    • 11.10.3 Abbott Laboratories Personalized Medicines In Oncology Introduction
    • 11.10.4 Abbott Laboratories Revenue in Personalized Medicines In Oncology Business (2016-2021)
    • 11.10.5 Abbott Laboratories Recent Development
  • 11.11 deCODE genetics
    • 11.11.1 deCODE genetics Company Details
    • 11.11.2 deCODE genetics Business Overview
    • 11.11.3 deCODE genetics Personalized Medicines In Oncology Introduction
    • 11.11.4 deCODE genetics Revenue in Personalized Medicines In Oncology Business (2016-2021)
    • 11.11.5 deCODE genetics Recent Development
  • 11.12 Exagen Inc
    • 11.12.1 Exagen Inc Company Details
    • 11.12.2 Exagen Inc Business Overview
    • 11.12.3 Exagen Inc Personalized Medicines In Oncology Introduction
    • 11.12.4 Exagen Inc Revenue in Personalized Medicines In Oncology Business (2016-2021)
    • 11.12.5 Exagen Inc Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Personalized Medicines In Oncology market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Personalized Medicines In Oncology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Service and by End Users in terms of revenue and forecast for the period 2016-2027.

    Segment by Service
    Molecular Oncopathology
    Genome Diagnostics
    Radiation Therapy
    Oncology Testing
    Chemotherapy
    Others

    Segment by End Users
    Research Centers
    Governmental Institutions
    Hospitals
    Clinical Centers
    Others

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Biotheranostics
    Illumina
    DNA Link
    Genomic Health, Inc.(Exact Sciences)
    Cypher Genomics(Human Longevity, Inc.)
    Life Technologies Corporation(Thermo Fisher Scientific)
    Fulgent Genetics
    Caris Life Sciences
    Ariana Pharma
    Genomic Health, Inc.(Exact Sciences)
    Cypher Genomics(Human Longevity, Inc.)


    Summary:
    Get latest Market Research Reports on Personalized Medicines In Oncology. Industry analysis & Market Report on Personalized Medicines In Oncology is a syndicated market report, published as Global Personalized Medicines In Oncology Market Size, Status and Forecast 2021-2027. It is complete Research Study and Industry Analysis of Personalized Medicines In Oncology market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    2,757.77
    4,136.66
    5,515.54
    3,203.80
    4,805.70
    6,407.61
    412,662.90
    618,994.35
    825,325.80
    282,178.26
    423,267.39
    564,356.52
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report